Literature DB >> 9841828

Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska.

K Galil1, R Singleton, O S Levine, M A Fitzgerald, L Bulkow, M Getty, B A Perkins, A Parkinson.   

Abstract

Before vaccination, Alaska Natives experienced very high rates of invasive Haemophilus influenzae type b (Hib) disease and carriage. Vaccination with Hib conjugate vaccine PRP-OMP (polyribosylribitol phosphate Neisseria meningitidis outer membrane protein) began in 1991 and resulted in a sharp decline in cases. In 1996, after switching to a different Hib conjugate vaccine, DTP-HbOC (which combines diphtheria-tetanus-whole cell pertussis vaccines with HbOC [Hib oligosaccharide CRM197]), cases of invasive Hib disease increased, suggesting ongoing Hib transmission despite widespread vaccination. To determine the prevalence of and risk factors for carriage, a cross-sectional study of oropharyngeal Hib carriage was conducted among Alaska Native children aged 1-5 years in remote southwestern Alaska. Of 496 children with swabs taken, 46 (9.3%) were colonized with Hib. Carriage rates varied by village from 2.2% to 13.2% and by age from 6.1% in 1-year-olds to 14.7% in 5-year-olds. Crowding was associated with Hib carriage. Widespread vaccination with PRP-OMP Hib conjugate vaccine did not eliminate carriage in this population of Alaska Natives, and ongoing carriage contributed to disease resurgence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9841828     DOI: 10.1086/314569

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Toward elimination of Haemophilus influenzae type B carriage and disease among high-risk American Indian children.

Authors:  E V Millar; K L O'Brien; O S Levine; S Kvamme; R Reid; M Santosham
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

2.  Measurement of serum bactericidal activity specific for Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicator.

Authors:  Sandra Romero-Steiner; Willie Spear; Nekeidra Brown; Patricia Holder; Thomas Hennessy; Patricia Gomez De Leon; George M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

3.  Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska.

Authors:  Henry C Baggett; Thomas W Hennessy; Lisa Bulkow; Sandra Romero-Steiner; Debra Hurlburt; Patricia Holder; Alan J Parkinson; Rosalyn J Singleton; Orin Levine; George M Carlone; Jay C Butler
Journal:  Clin Vaccine Immunol       Date:  2006-06

4.  Molecular epidemiology of Haemophilus influenzae type b causing vaccine failures in the United Kingdom.

Authors:  Belén Aracil; Mary Slack; María Pérez-Vázquez; Federico Román; Mary Ramsay; José Campos
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

5.  Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial.

Authors:  Nina Ekström; Heidi Ahman; Jouko Verho; Jukka Jokinen; Merja Väkeväinen; Terhi Kilpi; Helena Käyhty
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

6.  Characteristics of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and Staphylococcus aureus isolated from the nasopharynx of healthy children attending day-care centres in the Czech Republic.

Authors:  H Zemlicková; P Urbásková; V Adámková; J Motlová; V Lebedová; B Procházka
Journal:  Epidemiol Infect       Date:  2006-05-10       Impact factor: 2.451

7.  High level of sequence diversity in the 16S rRNA genes of Haemophilus influenzae isolates is useful for molecular subtyping.

Authors:  Claudio T Sacchi; Dietmar Alber; Peter Dull; Elizabeth A Mothershed; Anne M Whitney; Gwen A Barnett; Tanja Popovic; Leonard W Mayer
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

8.  Detection of Haemophilus influenzae type b by real-time PCR.

Authors:  Adrian Marty; Oliver Greiner; Philip J R Day; Sibylle Gunziger; Kathrin Mühlemann; David Nadal
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

Review 9.  Haemophilus influenzae type b conjugate vaccines.

Authors:  Dominic F Kelly; E Richard Moxon; Andrew J Pollard
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

10.  Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000-2005.

Authors:  Michael G Bruce; Shelley L Deeks; Tammy Zulz; Christine Navarro; Carolina Palacios; Cheryl Case; Colleen Hemsley; Tom Hennessy; Andre Corriveau; Bryce Larke; Isaac Sobel; Marguerite Lovgren; Carolynn Debyle; Raymond Tsang; Alan J Parkinson
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.